gamma-aminobutyric acid has been researched along with Amyloid Deposits in 8 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interestingly, astrogliosis observed in the BFB at the pre-plaque stage was absent at the early-plaque stage." | 1.72 | Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats. ( Adhikari, MH; De Vos, WH; Heymans, L; Keliris, GA; Missault, S; Pintelon, I; Ponsaerts, P; Van Audekerke, J; van den Berg, M; Van der Linden, A; Vasilkovska, T; Verhoye, M; Verschuuren, M, 2022) |
| "Furthermore, amyloid plaque size was shown to have a statistically significant effect on the relative area occupied by dystrophic glutamatergic neurites in the peri-plaque neuropile." | 1.32 | Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. ( Bell, KF; Cuello, AC; de Kort, GJ; Ribeiro-da-Silva, A; Shigemoto, R; Steggerda, S, 2003) |
| "While the cholinergic depletion in Alzheimer's disease (AD) has been known for some time, a definitive involvement of other neurotransmitter systems has been somewhat more elusive." | 1.32 | Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. ( Bell, KF; Cuello, AC; de Kort, GJ; Ribeiro-da-Silva, A; Shigemoto, R; Steggerda, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, K | 1 |
| Pradhan, S | 1 |
| Duffy, LK | 1 |
| Yeasmin, S | 1 |
| Bhattarai, N | 1 |
| Schulte, MK | 1 |
| van den Berg, M | 1 |
| Adhikari, MH | 1 |
| Verschuuren, M | 1 |
| Pintelon, I | 1 |
| Vasilkovska, T | 1 |
| Van Audekerke, J | 1 |
| Missault, S | 1 |
| Heymans, L | 1 |
| Ponsaerts, P | 1 |
| De Vos, WH | 1 |
| Van der Linden, A | 1 |
| Keliris, GA | 1 |
| Verhoye, M | 1 |
| Fernández-Pérez, EJ | 1 |
| Gallegos, S | 1 |
| Armijo-Weingart, L | 1 |
| Araya, A | 1 |
| Riffo-Lepe, NO | 1 |
| Cayuman, F | 1 |
| Aguayo, LG | 1 |
| Jo, S | 1 |
| Yarishkin, O | 1 |
| Hwang, YJ | 1 |
| Chun, YE | 1 |
| Park, M | 1 |
| Woo, DH | 1 |
| Bae, JY | 1 |
| Kim, T | 1 |
| Lee, J | 1 |
| Chun, H | 1 |
| Park, HJ | 1 |
| Lee, DY | 1 |
| Hong, J | 1 |
| Kim, HY | 1 |
| Oh, SJ | 1 |
| Park, SJ | 1 |
| Lee, H | 1 |
| Yoon, BE | 1 |
| Kim, Y | 1 |
| Jeong, Y | 1 |
| Shim, I | 1 |
| Bae, YC | 1 |
| Cho, J | 1 |
| Kowall, NW | 1 |
| Ryu, H | 1 |
| Hwang, E | 1 |
| Kim, D | 1 |
| Lee, CJ | 1 |
| Madhusudan, A | 1 |
| Sidler, C | 1 |
| Knuesel, I | 1 |
| Jolas, T | 1 |
| Zhang, XS | 1 |
| Zhang, Q | 1 |
| Wong, G | 1 |
| Del Vecchio, R | 1 |
| Gold, L | 1 |
| Priestley, T | 1 |
| Bell, KF | 1 |
| de Kort, GJ | 1 |
| Steggerda, S | 1 |
| Shigemoto, R | 1 |
| Ribeiro-da-Silva, A | 1 |
| Cuello, AC | 1 |
| Johansson, S | 1 |
| Radesäter, AC | 1 |
| Cowburn, RF | 1 |
| Thyberg, J | 1 |
| Luthman, J | 1 |
1 review available for gamma-aminobutyric acid and Amyloid Deposits
| Article | Year |
|---|---|
Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Neurofi | 2021 |
7 other studies available for gamma-aminobutyric acid and Amyloid Deposits
| Article | Year |
|---|---|
Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Basal Forebrain; Cholinergic Agents; Disease Mode | 2022 |
Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer's disease mouse model.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Biomarkers; Di | 2020 |
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Astrocytes; | 2014 |
Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging.
Topics: Aging; Analysis of Variance; Animals; Astrocytes; Calbindins; Cell Adhesion Molecules, Neuronal; Cel | 2009 |
Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe/ind) CRND8 mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Electroph | 2002 |
Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; | 2003 |
Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; CD11b Antigen; Cell Count; D | 2006 |